• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算策略评估不良结局途径:以肝脂肪变性为例。

Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study.

机构信息

ProtoQSAR S.L., Calle Nicolás Copérnico 6, Parque Tecnológico de Valencia, 46980 Paterna, Spain.

Unidad de Hepatología Experimental, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Av. Fernando Abril Martorell 106, 46026 Valencia, Spain.

出版信息

Int J Mol Sci. 2024 Oct 17;25(20):11154. doi: 10.3390/ijms252011154.

DOI:10.3390/ijms252011154
PMID:39456937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11508863/
Abstract

The evolving landscape of chemical risk assessment is increasingly focused on developing tiered, mechanistically driven approaches that avoid the use of animal experiments. In this context, adverse outcome pathways have gained importance for evaluating various types of chemical-induced toxicity. Using hepatic steatosis as a case study, this review explores the use of diverse computational techniques, such as structure-activity relationship models, quantitative structure-activity relationship models, read-across methods, omics data analysis, and structure-based approaches to fill data gaps within adverse outcome pathway networks. Emphasizing the regulatory acceptance of each technique, we examine how these methodologies can be integrated to provide a comprehensive understanding of chemical toxicity. This review highlights the transformative impact of in silico techniques in toxicology, proposing guidelines for their application in evidence gathering for developing and filling data gaps in adverse outcome pathway networks. These guidelines can be applied to other cases, advancing the field of toxicological risk assessment.

摘要

化学风险评估的不断发展的格局越来越注重开发分层的、基于机制的方法,避免使用动物实验。在这种情况下,不良结局途径在评估各种类型的化学诱导毒性方面变得越来越重要。本文以肝脂肪变性为例,探讨了多种计算技术的应用,如结构-活性关系模型、定量结构-活性关系模型、读-写方法、组学数据分析和基于结构的方法,以填补不良结局途径网络中的数据空白。强调了每种技术的监管接受程度,我们研究了如何将这些方法整合起来,以提供对化学毒性的全面理解。本文强调了计算技术在毒理学中的变革性影响,提出了应用这些技术在不良结局途径网络中积累和填补数据空白的指南。这些指南可以应用于其他情况,推动毒理学风险评估领域的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/66661b0fb263/ijms-25-11154-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/2ee3e4982a3d/ijms-25-11154-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/fff30bd1b154/ijms-25-11154-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/9143439e7aa5/ijms-25-11154-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/8bc9fea775a5/ijms-25-11154-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/9856cc850261/ijms-25-11154-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/17cbb794500e/ijms-25-11154-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/36a9ba91c273/ijms-25-11154-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/66661b0fb263/ijms-25-11154-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/2ee3e4982a3d/ijms-25-11154-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/fff30bd1b154/ijms-25-11154-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/9143439e7aa5/ijms-25-11154-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/8bc9fea775a5/ijms-25-11154-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/9856cc850261/ijms-25-11154-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/17cbb794500e/ijms-25-11154-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/36a9ba91c273/ijms-25-11154-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c36/11508863/66661b0fb263/ijms-25-11154-g008.jpg

相似文献

1
Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study.计算策略评估不良结局途径:以肝脂肪变性为例。
Int J Mol Sci. 2024 Oct 17;25(20):11154. doi: 10.3390/ijms252011154.
2
Adverse Outcome Pathways Mechanistically Describing Hepatotoxicity.不良结局途径对肝毒性的机制描述。
Methods Mol Biol. 2025;2834:249-273. doi: 10.1007/978-1-0716-4003-6_12.
3
A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: A case study on chemical-induced liver steatosis.一种用于不良结局途径网络置信度评估的定量证据权重法:以化学物质诱导的肝脂肪变性为例
Toxicology. 2024 Jun;505:153814. doi: 10.1016/j.tox.2024.153814. Epub 2024 Apr 25.
4
Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole.基于不良结局路径的体外肝脂肪变性分析:以环丙孕酮为例的案例研究。
Chem Res Toxicol. 2018 Aug 20;31(8):784-798. doi: 10.1021/acs.chemrestox.8b00112. Epub 2018 Jul 11.
5
QSAR Modeling of ToxCast Assays Relevant to the Molecular Initiating Events of AOPs Leading to Hepatic Steatosis.QSAR 模型构建——预测导致脂肪性肝病的 AOPs 的分子起始事件的 ToxCast 检测结果。
J Chem Inf Model. 2018 Aug 27;58(8):1501-1517. doi: 10.1021/acs.jcim.8b00297. Epub 2018 Jul 26.
6
Toxicity testing in the 21st century: progress in the past decade and future perspectives.二十一世纪的毒性测试:过去十年的进展与未来展望。
Arch Toxicol. 2020 Jan;94(1):1-58. doi: 10.1007/s00204-019-02613-4. Epub 2019 Dec 17.
7
Predicting the Probability that a Chemical Causes Steatosis Using Adverse Outcome Pathway Bayesian Networks (AOPBNs).利用不良结局途径贝叶斯网络(AOPBNs)预测化学物质引起脂肪变性的概率。
Risk Anal. 2020 Mar;40(3):512-523. doi: 10.1111/risa.13423. Epub 2019 Nov 13.
8
The path via pathway-based approaches towards safety assessment: A concise review.基于通路方法的安全性评估路径:简要综述。
Toxicol Appl Pharmacol. 2022 Oct 1;452:116195. doi: 10.1016/j.taap.2022.116195. Epub 2022 Aug 14.
9
Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.美国环保署实施的计算毒理学:为筛选和评估化学暴露、危害和风险提供高通量决策支持工具。
J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):197-217. doi: 10.1080/10937404.2010.483935.
10
Editor's Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis.编辑亮点:基于肝脂肪变性不良结局途径网络的机制毒性测试。
Toxicol Sci. 2017 Sep 1;159(1):159-169. doi: 10.1093/toxsci/kfx121.

引用本文的文献

1
Impact of halogenation on scaffold toxicity assessed using HD-GEM machine learning model.使用HD-GEM机器学习模型评估卤化对支架毒性的影响。
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf347.
2
Association between serum Copper-Zinc-Selenium mixture and multiple health outcomes.血清铜-锌-硒混合物与多种健康结局之间的关联。
Bioact Mater. 2025 Apr 24;50:432-442. doi: 10.1016/j.bioactmat.2025.04.004. eCollection 2025 Aug.

本文引用的文献

1
The VERA software: Implementation of the acute fish toxicity endpoint and its application to pharmaceutical compounds.VERA 软件:急性鱼类毒性终点的实现及其在药物化合物中的应用。
Chemosphere. 2024 Jun;358:142232. doi: 10.1016/j.chemosphere.2024.142232. Epub 2024 May 5.
2
A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: A case study on chemical-induced liver steatosis.一种用于不良结局途径网络置信度评估的定量证据权重法:以化学物质诱导的肝脂肪变性为例
Toxicology. 2024 Jun;505:153814. doi: 10.1016/j.tox.2024.153814. Epub 2024 Apr 25.
3
Bioactivity descriptors for in vivo toxicity prediction: now and the future.
用于体内毒性预测的生物活性描述符:现状与未来。
Expert Opin Drug Metab Toxicol. 2024 Jul;20(7):541-543. doi: 10.1080/17425255.2024.2334308. Epub 2024 Apr 4.
4
Uncovering the toxicity mechanisms of a series of carboxylic acids in liver cells through computational and experimental approaches.通过计算和实验方法揭示一系列羧酸在肝细胞中的毒性机制。
Toxicology. 2024 May;504:153764. doi: 10.1016/j.tox.2024.153764. Epub 2024 Feb 28.
5
Artificial intelligence (AI)-it's the end of the tox as we know it (and I feel fine).人工智能(AI)——这是我们所知道的毒理学的终结(我感觉很好)。
Arch Toxicol. 2024 Mar;98(3):735-754. doi: 10.1007/s00204-023-03666-2. Epub 2024 Jan 20.
6
Toxicometabolomics as a tool for next generation environmental risk assessment.毒理代谢组学作为下一代环境风险评估的工具。
EFSA J. 2023 Nov 30;21(Suppl 1):e211005. doi: 10.2903/j.efsa.2023.e211005. eCollection 2023 Nov.
7
Applying proteomics in metabolic dysfunction-associated steatotic liver disease: From mechanism to biomarkers.应用蛋白质组学研究代谢功能障碍相关脂肪性肝病:从机制到生物标志物。
Clin Res Hepatol Gastroenterol. 2023 Dec;47(10):102230. doi: 10.1016/j.clinre.2023.102230. Epub 2023 Nov 4.
8
PaxDb 5.0: Curated Protein Quantification Data Suggests Adaptive Proteome Changes in Yeasts.PaxDb 5.0:经过整理的蛋白质定量数据表明酵母中蛋白质组的适应性变化。
Mol Cell Proteomics. 2023 Oct;22(10):100640. doi: 10.1016/j.mcpro.2023.100640. Epub 2023 Aug 31.
9
A multi-omics dataset of human transcriptome and proteome stable reference.人类转录组和蛋白质组稳定参考的多组学数据集。
Sci Data. 2023 Jul 13;10(1):455. doi: 10.1038/s41597-023-02359-w.
10
Ten quick tips for avoiding pitfalls in multi-omics data integration analyses.避免组学数据整合分析陷阱的 10 个快速技巧。
PLoS Comput Biol. 2023 Jul 6;19(7):e1011224. doi: 10.1371/journal.pcbi.1011224. eCollection 2023 Jul.